Trial Profile

A randomized, open-label, multicenter, two-period crossover study to evaluate the 24 hour bronchodilator profile of Tiotropium Bromide Respimat administered once daily versus twice daily in patients with Chronic Obstructive Pulmonary Disease (COPD).

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 Apr 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database record.
21 Jun 2012 Additional company (Boehringer Ingelheim) added in association as reported by European Clinical Trials Database.
06 Aug 2011 This trial is recruiting in France and has completed in Great Britain.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com